Abeona Therapeutics Inc [NASDAQ: ABEO] stock went on an upward path that rose over 0.34% on Thursday, amounting to a one-week price decrease of less than -0.17%.
Over the last 12 months, ABEO stock rose by 5.75%. The one-year Abeona Therapeutics Inc stock forecast points to a potential upside of 70.45. The average equity rating for ABEO stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $301.31 million, with 48.95 million shares outstanding and 45.31 million shares in the current float. Compared to the average trading volume of 1.85M shares, ABEO stock reached a trading volume of 372932 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Abeona Therapeutics Inc [ABEO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABEO shares is $19.93 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABEO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Abeona Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 02, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on March 05, 2025, representing the official price target for Abeona Therapeutics Inc stock. Previously, the target price had yet another raise to $15, while H.C. Wainwright analysts kept a Buy rating on ABEO stock.
The Price to Book ratio for the last quarter was 6.97, with the Price to Cash per share for the same quarter was set at 1.65.
ABEO Stock Performance Analysis:
Abeona Therapeutics Inc [ABEO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.17. With this latest performance, ABEO shares dropped by -6.06% in over the last four-week period, additionally plugging by 4.99% over the last 6 months – not to mention a rise of 5.75% in the past year of trading.
Insight into Abeona Therapeutics Inc Fundamentals:
Return on Equity for this stock declined to -50.73%, with Return on Assets sitting at -50.73%.
Abeona Therapeutics Inc [ABEO] Institutonal Ownership Details
There are presently around $63.36%, or 67.50% of ABEO stock, in the hands of institutional investors.
